These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9694035

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neuroleptic malignant syndrome with risperidone.
    Levin GM, Lazowick AL, Powell HS.
    J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
    [No Abstract] [Full Text] [Related]

  • 3. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB.
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O, Kurtz G, Müller-Felber W, Modell S.
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [Abstract] [Full Text] [Related]

  • 9. [Neurotoxicity related to lithium-risperidon combination treatment in a patient with schizoaffective disorder].
    Böker H, Brandenberger M, Schopper C.
    Psychiatr Prax; 2007 Jan; 34(1):38-41. PubMed ID: 17106843
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risperidone and NMS?
    Murray S, Haller E.
    Psychiatr Serv; 1995 Sep; 46(9):951. PubMed ID: 7583513
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuroleptic malignant syndrome with risperidone.
    Gleason PP, Conigliaro RL.
    Pharmacotherapy; 1997 Sep; 17(3):617-21. PubMed ID: 9165568
    [Abstract] [Full Text] [Related]

  • 14. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S, Buckley P.
    Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F, Geerlings CJ, Rietveld AP.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract] [Full Text] [Related]

  • 18. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T, Westendorp RG.
    Ned Tijdschr Geneeskd; 2005 Mar 12; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract] [Full Text] [Related]

  • 19. Dysphagia in the neuroleptic malignant syndrome.
    Shamash J, Miall L, Williams F, Creamer D, Robinson S, Johnston DG.
    Br J Psychiatry; 1994 Jun 12; 164(6):849-50. PubMed ID: 7953002
    [No Abstract] [Full Text] [Related]

  • 20. Neuroleptic rechallenge after neuroleptic malignant syndrome.
    Giacardi-Paty M, Bottai T, Pujalte D, Lainey E, Petit P.
    Br J Psychiatry; 1993 Jul 12; 163():121-2. PubMed ID: 8102585
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.